Dendritic Cell Vaccination (Radboud University)

N/A

Report date: 2023/03/20 20:00:20

Base Information

Drug NameDendritic Cell Vaccination (Radboud University)

Drug Alias NameXP-DC vaccinations (Radboud University)Dendritic cell vaccine (Radboud University)cdc1 (Radboud University)

ClassificationVaccines > Development/production technology > Dendritic cell vaccineCell and gene therapy > Cell therapy > Immune system cell therapy > Dendritic cell therapy > Dendritic cell vaccineVaccines > Application > Therapeutic vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsCarcinoma, Ovarian Epithelial

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryNetherlands

CombinationsNo

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaN/A

Originator CompaniesRadboud University Medical Center

China Registration ClassN/A

Develop Information

Active CompaniesRadboud University Medical Center

Inactive CompaniesN/A

Active IndicationsCarcinoma, Ovarian Epithelial

Inactive IndicationsN/A

Other Information

ATC CodeN/A